Cagrilintide

Cagrilintide  that mimics amylin, a hormone naturally released by the pancreas along with insulin. It has been developed primarily for obesity and weight management.

Potential benefits demonstrated in clinical trials include:

• Significant weight loss: Cagrilintide reduces appetite and increases feelings of fullness.
• Reduced hunger and food intake: By acting on the brain's satiety centers and slowing stomach emptying, many people eat less without feeling as hungry.
• Improved blood sugar control: In people with obesity and type 2 diabetes.
• Potential improvements in metabolic health: Weight loss from cagrilintide may lead to improvements in blood pressure, cholesterol, waist circumference, andinsulin sensitivity, although these benefits are largely secondary to weight reduction.

How it works

Cagrilintide is a long-acting amylin analogue. It:

• Increases satiety (helps you feel fullsooner).
• Slows gastric emptying.
• Reduces appetite and food cravings.
• Works through a different pathway thanGLP-1 medications, which is why combining it with drugs like semaglutide may produce greater weight loss than either medication alone.